MarketInOut Stock Screener Log In | Sign Up
 

Sandoz Group AG

SIX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026 17:30
Sandoz Group AG stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSIX
Market Capitalization30,202 mln
Float415 mln
Earnings Date10/30/2026

EPS

1.17
Stretched

P / E

69.26
Richly valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.61
Likely reliable

1-Year Forecast

76.36
Limited downside

Relative Strength

99 / 100
Top performer

Business Description

Sandoz Group AG is a Swiss pharmaceutical company founded in 1886 and based in Basel, with operations spanning the globe. The company specializes in generic medicines and biosimilars, offering affordable treatment options across a broad range of health conditions, from heart disease and cancer to rare disorders and diabetes. Sandoz also supplies the raw pharmaceutical ingredients and finished drug products that other manufacturers and healthcare providers rely on.

Key Fundamentals

EPS1.17
P/E69.26
ROE7.12
RPS22.07
ROIC7.29
ROA2.91
Interest Cover8.14
EBITDA, mln1,310
EV / EBITDA27.15
EV / EBIT42.19
Revenue, mln9,215
EV / Revenue3.86

Quote Details

Last 80.66
Change 1.66 (2.1%)
Open 78.24
Volume 1,168,306
Turnover 94,235,568
Average Volume 1,000,861

Financial Ratios

Pre-Tax Profit Margin7
Leverage Ratio2.53
Current Ratio1.05
Price / Book4.22
Price / Cash Flow18.98
Price / Free Cash Flow28.71
Debt / Equity0.69
Price / Sales3.37
PEG Ratio1.06

Financial Strength

Altman Z-Score3.24
Piotroski F-Score 5 / 9
Beneish M-Score-2.61
1-Year Target Price76.36

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.51% 96 / 100   
1 Month 13.96% 98 / 100   
2 Months 21.22% 93 / 100   
6 Months 28.36% 94 / 100   
1 Year 69.49% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog